Cardiorenal Syndrome
Renal capacity, as reflected by serum creatinine, or all the more unequivocally by assessed glomerular filtration rate (eGFR), is relentlessly the best indicator of cardiovascular results in an expansive range of populaces. This incorporates higher hazard patients, for example, those postmyocardial localized necrosis, and those with diabetes or congestive cardiovascular breakdown. The new center ought to be to perceive the cardiorenal disorder, and treat the entire patient, and treat for long haul.
Related Conference of Cardiorenal Syndrome
October 29-30, 2026
14th European Congress on Nephrology, Internal Medicine and Kidney Diseases
Paris, France